Janelle R. Anderson, PhD, Managing Partner of CTI Life Sciences Fund, has started a new podcast, Human Proof of Concept, in which she interviews business leaders within the life sciences and venture capital spaces. The goal is to bring light to new medicine and technology.
In the first two episodes, She speaks with Ron Cohen, CEO and founder of Acorda Therapeutics and Chair of BIO. In the interviews, he discusses his career and its challenges/successes, comments on the high drama from 2015 and how it has affected the industry and also discusses the drug pricing conversation that has been especially prevalent lately. He also touches on new trends for biotech coming up.
Image: http://medcitynews.com
